MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Leukemia & lymphoma/Leukemia and lymphoma
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

430 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
430 works in the cohort · of 4,299,418page 2 of 9

Labels cover 0 of 430 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 430 of 430 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affaboutunlabeled
A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186
David MacDonald, Sarit Assouline, Joseph Brandwein, Suzanne Kamel‐Reid, Elizabeth A. Eisenhauer, Stephen Couban +4 more
2012· article· en· Leukemia & lymphoma/Leukemia and lymphoma· Medicine
machine prediction:candidate · noneconsensus · none
45
citations
affunlabeled
First among equals: The cancer cell hierarchy
Christine V. Ichim, Richard A. Wells
2006· review· en· Leukemia & lymphoma/Leukemia and lymphoma· Medicine
machine prediction:candidate · noneconsensus · none
40
citations
affunlabeled
High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi study
Michael Mian, Gianluca Gaïdano, Annarita Conconi, Richard Tsang, Mary Gospodarowicz, Alessandro Rambaldi +14 more
2011· article· en· Leukemia & lymphoma/Leukemia and lymphoma· Medicine
machine prediction:candidate · noneconsensus · none
32
citations
affunlabeled
Study of specific genetic and epigenetic variables in multiple myeloma
Eleftheria Hatzimichael, Aggeliki Dasoula, Leonidas Benetatos, Nelofer Syed, George Dranitsaris, Tim Crook +1 more
2010· article· en· Leukemia & lymphoma/Leukemia and lymphoma· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
31
citations

How this was built: Screen · Findings · About